Comparative performance of two automated machine learning platforms for COVID-19 detection by MALDI-TOF-MS
Fig 1
Comparison of molecular, antigen, and ML-enhanced MALDI-TOF-MS workflows.
The figure illustrates the tradeoffs of (A) high throughput molecular platforms, (B) point-of-care molecular platforms, and (C) our proposed MALDI-TOF-MS method.